Highlights in MS research from EAN 2021

In an EAN highlights session, Professor Christian Enzinger of the Medical University of Graz, Austria, selected key presentations to highlight regarding research in multiple sclerosis (MS).

His selection included a study by Comi et al (EPR-056) on the effects of treatment on work productivity. Data from the phase 3 CASTING study showed that work productivity scores improved over 2 years of treatment with ocrelizumab in patients with relapsing-remitting MS after failure of 1-2 prior disease-modifying therapies. Improvement in work productivity correlated with reduced MS symptom burden.